FH fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Filament Health Corp. is a clinical-stage natural psychedelic drug development company, which engages in the discovery and development of natural psychedelic pharmaceuticals. It focuses on the discovery, development, and delivery of natural psychedelic medicines for clinical development. The company was founded by Benjamin Lightburn and Tom Kineshanko on June 8, 2020 and is headquartered in Burnaby, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
FH has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company